Regenerative medicine is redefining how clinics approach hair restoration. Instead of relying only on mechanical stimulation or transplants, new biologic protocols aim to repair and renew the scalp itself. The most comprehensive approach now combines Wharton’s Jelly mesenchymal stem cells (MSCs), platelet lysate (PL), and autologous fibroblasts.
Hair Loss
Androgenetic alopecia (AGA), commonly known as pattern hair loss, affects over 50 million men and 30 million women in the U.S. It is characterized by the progressive miniaturization of hair follicles due to genetic and hormonal factors, particularly sensitivity to dihydrotestosterone (DHT). Traditional treatments like minoxidil and finasteride can slow hair loss but often have limited efficacy and potential side effects.